Why is Intuitive Surgical, Inc. ?
1
High Management Efficiency with a high ROE of 13.26%
2
Company has a low Debt to Equity ratio (avg) at times
3
Healthy long term growth as Net Sales has grown by an annual rate of 18.22%
4
With a growth in Operating Profit of 22.08%, the company declared Very Positive results in Dec 25
- OPERATING CASH FLOW(Y) Highest at USD 3,030.5 MM
- ROCE(HY) Highest at 16.67%
- NET SALES(Q) Highest at USD 2,866.2 MM
5
With ROE of 14.91%, it has a expensive valuation with a 9.21 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -8.99%, its profits have risen by 25% ; the PEG ratio of the company is 2.5
6
High Institutional Holdings at 87.17%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 17.45% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -8.99% returns
How much should you hold?
- Overall Portfolio exposure to Intuitive Surgical, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Intuitive Surgical, Inc. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Intuitive Surgical, Inc.
-4.77%
0.50
34.28%
S&P 500
17.45%
0.90
19.38%
Quality key factors
Factor
Value
Sales Growth (5y)
18.22%
EBIT Growth (5y)
22.92%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.53
Tax Ratio
11.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
87.17%
ROCE (avg)
21.41%
ROE (avg)
13.26%
Valuation Key Factors 
Factor
Value
P/E Ratio
62
Industry P/E
Price to Book Value
9.21
EV to EBIT
60.38
EV to EBITDA
50.15
EV to Capital Employed
12.70
EV to Sales
17.39
PEG Ratio
2.54
Dividend Yield
NA
ROCE (Latest)
21.04%
ROE (Latest)
14.91%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
10What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 3,030.5 MM
ROCE(HY)
Highest at 16.67%
NET SALES(Q)
Highest at USD 2,866.2 MM
OPERATING PROFIT(Q)
Highest at USD 1,036 MM
PRE-TAX PROFIT(Q)
Highest at USD 934.3 MM
NET PROFIT(Q)
Highest at USD 776.98 MM
EPS(Q)
Highest at USD 2.21
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Intuitive Surgical, Inc.
Operating Cash Flow
Highest at USD 3,030.5 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 2,866.2 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 1,036 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 934.3 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 776.98 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 2.21
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Depreciation
Highest at USD 171.7 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)






